Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Sci Rep ; 10(1): 13282, 2020 08 06.
Artículo en Inglés | MEDLINE | ID: mdl-32764642

RESUMEN

Pulmonary involvement occurs in up to 95% of sarcoidosis cases. In this pilot study, we examine lung compartment-specific protein expression to identify pathways linked to development and progression of pulmonary sarcoidosis. We characterized bronchoalveolar lavage (BAL) cells and fluid (BALF) proteins in recently diagnosed sarcoidosis cases. We identified 4,306 proteins in BAL cells, of which 272 proteins were differentially expressed in sarcoidosis compared to controls. These proteins map to novel pathways such as integrin-linked kinase and IL-8 signaling and previously implicated pathways in sarcoidosis, including phagosome maturation, clathrin-mediated endocytic signaling and redox balance. In the BALF, the differentially expressed proteins map to several pathways identified in the BAL cells. The differentially expressed BALF proteins also map to aryl hydrocarbon signaling, communication between innate and adaptive immune response, integrin, PTEN and phospholipase C signaling, serotonin and tryptophan metabolism, autophagy, and B cell receptor signaling. Additional pathways that were different between progressive and non-progressive sarcoidosis in the BALF included CD28 signaling and PFKFB4 signaling. Our studies demonstrate the power of contemporary proteomics to reveal novel mechanisms operational in sarcoidosis. Application of our workflows in well-phenotyped large cohorts maybe beneficial to identify biomarkers for diagnosis and prognosis and therapeutically tenable molecular mechanisms.


Asunto(s)
Progresión de la Enfermedad , Proteínas/metabolismo , Sarcoidosis Pulmonar/metabolismo , Adulto , Líquido del Lavado Bronquioalveolar/química , Estudios de Casos y Controles , Femenino , Humanos , Masculino , Persona de Mediana Edad , Fenotipo , Proyectos Piloto , Sarcoidosis Pulmonar/patología
2.
Am J Respir Cell Mol Biol ; 21(5): 576-85, 1999 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-10536117

RESUMEN

Surfactant protein (SP)-D is an oligomeric glycoprotein belonging to the family of collagen-like lectins known as collectins, which have previously been shown to stimulate phagocytosis and other immune cell functions. The hypothesis investigated in this study was that SP-D would stimulate the phagocytosis of an important pulmonary pathogen, Pseudomonas aeruginosa. SP-D, isolated from the lavage fluid of silica-treated rats, significantly enhanced the uptake of three of six strains of P. aeruginosa by rat alveolar macrophages as analyzed by both fluorescence and electron microscopy. SP-D had only minimal effects on phagocytosis of Haemophilus influenzae. SP-D bound to live P. aeruginosa, and binding was inhibited by chelation of calcium and by a competing saccharide, inositol. In vitro killing assays demonstrated that macrophage-mediated killing of one of the mucoid strains of P. aeruginosa was modestly enhanced by SP-D. P. aeruginosa was not measurably aggregated by SP-D either macroscopically or microscopically. Further, SP-D does not appear to act as an activation ligand because adherence of macrophages to SP-D- coated slides did not stimulate the uptake of P. aeruginosa. These findings suggest that SP-D may be important in controlling the pathogenesis of P. aeruginosa in the lung.


Asunto(s)
Glicoproteínas/farmacología , Macrófagos Alveolares/efectos de los fármacos , Fagocitosis/efectos de los fármacos , Pseudomonas aeruginosa/inmunología , Surfactantes Pulmonares/farmacología , Animales , Unión Competitiva/efectos de los fármacos , Células Cultivadas , Relación Dosis-Respuesta a Droga , Citometría de Flujo , Glicoproteínas/metabolismo , Calor , Activación de Macrófagos/efectos de los fármacos , Macrófagos Alveolares/inmunología , Macrófagos Alveolares/microbiología , Macrófagos Alveolares/ultraestructura , Masculino , Maltosa/farmacología , Microscopía Electrónica , Microscopía Fluorescente , Proteínas Opsoninas/farmacología , Fagocitosis/inmunología , Pseudomonas aeruginosa/citología , Pseudomonas aeruginosa/metabolismo , Proteína D Asociada a Surfactante Pulmonar , Surfactantes Pulmonares/metabolismo , Ratas
3.
Am J Physiol ; 276(4): L650-8, 1999 04.
Artículo en Inglés | MEDLINE | ID: mdl-10198363

RESUMEN

Surfactant protein (SP) A and SP-D affect numerous functions of immune cells including enhancing phagocytosis of bacteria and production of reactive species. Previous studies have shown that SP-A and SP-D bind to a variety of bacteria and to the lipopolysaccharide (LPS) components of their cell walls. In addition, purified preparations of SPs often contain endotoxin. The goals of this study were 1) to evaluate the effects of SP-A and SP-D and complexes of SPs and LPS on the production of nitric oxide metabolites by rat alveolar macrophages and 2) to evaluate methods for the removal of endotoxin with optimal recovery of SP. Incubation of SP-A or SP-D with polymyxin, 100 mM N-octyl-beta-D-glucopyranoside, and 2 mM EDTA followed by dialysis was the most effective method of those tested for reducing endotoxin levels. Commonly used storage buffers for SP-D, but not for SP-A, inhibited the detection of endotoxin. There was a correlation between the endotoxin content of the SP-A and SP-D preparations and their ability to stimulate production of nitrite by alveolar macrophages. SP-A and SP-D treated as described above to remove endotoxin did not stimulate nitrite production. These studies suggest that the functions of SP-A and SP-D are affected by endotoxin and illustrate the importance of monitoring SP preparations for endotoxin contamination.


Asunto(s)
Endotoxinas/farmacología , Glicoproteínas/metabolismo , Lipopolisacáridos/farmacología , Macrófagos Alveolares/fisiología , Óxido Nítrico/biosíntesis , Proteolípidos/metabolismo , Surfactantes Pulmonares/metabolismo , Animales , Supervivencia Celular/efectos de los fármacos , Células Cultivadas , Ácido Edético/farmacología , Endotoxinas/aislamiento & purificación , Glucósidos/farmacología , Glicoproteínas/efectos de los fármacos , Glicoproteínas/aislamiento & purificación , Cinética , Lipopolisacáridos/aislamiento & purificación , Macrófagos Alveolares/citología , Macrófagos Alveolares/efectos de los fármacos , Masculino , Nitritos/análisis , Fagocitosis , Polimixinas/farmacología , Proteolípidos/efectos de los fármacos , Proteolípidos/aislamiento & purificación , Proteína A Asociada a Surfactante Pulmonar , Proteína D Asociada a Surfactante Pulmonar , Proteínas Asociadas a Surfactante Pulmonar , Surfactantes Pulmonares/efectos de los fármacos , Surfactantes Pulmonares/aislamiento & purificación , Ratas , Ratas Sprague-Dawley
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...